These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27930551)

  • 1. Assessment of 2013 AHA/ACC ASCVD risk scores with behavioral characteristics of an urban cohort in India: Preliminary analysis of Noncommunicable disease Initiatives and Research at AMrita (NIRAM) study.
    Menon VP; Edathadathil F; Sathyapalan D; Moni M; Don A; Balachandran S; Pushpa B; Prasanna P; Sivaram N; Nair A; Vinod N; Jayaprasad R; Menon V
    Medicine (Baltimore); 2016 Dec; 95(49):e5542. PubMed ID: 27930551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough?
    Ozen G; Sunbul M; Atagunduz P; Direskeneli H; Tigen K; Inanc N
    Rheumatology (Oxford); 2016 Mar; 55(3):513-22. PubMed ID: 26472565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
    Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
    PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort.
    DeFilippis AP; Young R; McEvoy JW; Michos ED; Sandfort V; Kronmal RA; McClelland RL; Blaha MJ
    Eur Heart J; 2017 Feb; 38(8):598-608. PubMed ID: 27436865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.
    DeFilippis AP; Young R; Carrubba CJ; McEvoy JW; Budoff MJ; Blumenthal RS; Kronmal RA; McClelland RL; Nasir K; Blaha MJ
    Ann Intern Med; 2015 Feb; 162(4):266-75. PubMed ID: 25686167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease.
    Ofori S; Dodiyi-Manuel S; Akpa MR
    J Clin Lipidol; 2017; 11(6):1441-1447. PubMed ID: 29050979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk assessment using ASCVD risk score in fibromyalgia: a single-centre, retrospective study using "traditional" case control methodology and "novel" machine learning.
    Surendran S; Mithun CB; Moni M; Tiwari A; Pradeep M
    Adv Rheumatol; 2021 Nov; 61(1):72. PubMed ID: 34838137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination between Obstructive Coronary Artery Disease and Cardiac Syndrome X in Women with Typical Angina and Positive Exercise Test; Utility of Cardiovascular Risk Calculators.
    Saadat M; Masoudkabir F; Afarideh M; Ghodsi S; Vasheghani-Farahani A
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30646563
    [No Abstract]   [Full Text] [Related]  

  • 9. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
    Mortensen MB; Nordestgaard BG; Afzal S; Falk E
    Eur Heart J; 2017 Feb; 38(8):586-594. PubMed ID: 28363217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
    JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses.
    Garg N; Muduli SK; Kapoor A; Tewari S; Kumar S; Khanna R; Goel PK
    Indian Heart J; 2017; 69(4):458-463. PubMed ID: 28822511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new pooled cohort equations risk calculator.
    Preiss D; Kristensen SL
    Can J Cardiol; 2015 May; 31(5):613-9. PubMed ID: 25843167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study.
    Zibaeenejad F; Mohammadi SS; Sayadi M; Safari F; Zibaeenezhad MJ
    BMC Cardiovasc Disord; 2022 Apr; 22(1):162. PubMed ID: 35397522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.
    Mortensen MB; Nordestgaard BG
    JAMA Cardiol; 2019 Nov; 4(11):1131-1138. PubMed ID: 31577339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores.
    Kawai VK; Chung CP; Solus JF; Oeser A; Raggi P; Stein CM
    Arthritis Rheumatol; 2015 Feb; 67(2):381-5. PubMed ID: 25371313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).
    Yeboah J; Sillau S; Delaney JC; Blaha MJ; Michos ED; Young R; Qureshi WT; McClelland R; Burke GL; Psaty BM; Herrington DM
    Am Heart J; 2015 Mar; 169(3):387-395.e3. PubMed ID: 25728729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Disease Risk Score: Results from the Filipino-American Women Cardiovascular Study.
    Ancheta IB; Battie CA; Volgman AS; Ancheta CV; Palaniappan L
    J Racial Ethn Health Disparities; 2017 Feb; 4(1):25-34. PubMed ID: 27294770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
    Rana JS; Tabada GH; Solomon MD; Lo JC; Jaffe MG; Sung SH; Ballantyne CM; Go AS
    J Am Coll Cardiol; 2016 May; 67(18):2118-2130. PubMed ID: 27151343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
    Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
    Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.